These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of polymorphisms in the ICOS and ICOSL genes with the pathogenesis of autoimmune thyroid diseases. Yoshie N; Watanabe M; Inoue N; Kawaguchi H; Hidaka Y; Iwatani Y Endocr J; 2016; 63(1):61-8. PubMed ID: 26560438 [TBL] [Abstract][Full Text] [Related]
5. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production. Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472 [TBL] [Abstract][Full Text] [Related]
6. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Xu H; Li X; Liu D; Li J; Zhang X; Chen X; Hou S; Peng L; Xu C; Liu W; Zhang L; Qi H Nature; 2013 Apr; 496(7446):523-7. PubMed ID: 23619696 [TBL] [Abstract][Full Text] [Related]
7. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice. Hamel KM; Cao Y; Olalekan SA; Finnegan A Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576 [TBL] [Abstract][Full Text] [Related]
8. Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients. Zhan XK; Liu XK; Zhang S; Chen H Animal Model Exp Med; 2023 Oct; 6(5):464-473. PubMed ID: 37850501 [TBL] [Abstract][Full Text] [Related]
9. T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Liu D; Xu H; Shih C; Wan Z; Ma X; Ma W; Luo D; Qi H Nature; 2015 Jan; 517(7533):214-8. PubMed ID: 25317561 [TBL] [Abstract][Full Text] [Related]
10. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients. Wang F; Yan T; Chen L; Chen X; Liu T; Shen S; Li T; Gao L; Wang T; Sun J; Liu C; Wu H; Zhang X; Chen L J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735 [TBL] [Abstract][Full Text] [Related]
11. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis. Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257 [TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. Angulo G; Zeleznjak J; Martínez-Vicente P; Puñet-Ortiz J; Hengel H; Messerle M; Oxenius A; Jonjic S; Krmpotić A; Engel P; Angulo A Elife; 2021 Jan; 10():. PubMed ID: 33459589 [TBL] [Abstract][Full Text] [Related]
13. CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function. Goenka R; Xu Z; Samayoa J; Banach D; Beam C; Bose S; Dooner G; Forsyth CM; Lu X; Medina L; Sadhukhan R; Sielaff B; Sousa S; Tao Q; Touw D; Wu F; Kingsbury GA; Akamatsu Y J Immunol; 2021 Mar; 206(5):1102-1113. PubMed ID: 33495237 [TBL] [Abstract][Full Text] [Related]
14. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment. Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822 [TBL] [Abstract][Full Text] [Related]
15. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells. Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S Front Immunol; 2018; 9():2227. PubMed ID: 30319662 [TBL] [Abstract][Full Text] [Related]
16. Loss of human ICOSL results in combined immunodeficiency. Roussel L; Landekic M; Golizeh M; Gavino C; Zhong MC; Chen J; Faubert D; Blanchet-Cohen A; Dansereau L; Parent MA; Marin S; Luo J; Le C; Ford BR; Langelier M; King IL; Divangahi M; Foulkes WD; Veillette A; Vinh DC J Exp Med; 2018 Dec; 215(12):3151-3164. PubMed ID: 30498080 [TBL] [Abstract][Full Text] [Related]
17. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus. Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres. Pratama A; Srivastava M; Williams NJ; Papa I; Lee SK; Dinh XT; Hutloff A; Jordan MA; Zhao JL; Casellas R; Athanasopoulos V; Vinuesa CG Nat Commun; 2015 Mar; 6():6436. PubMed ID: 25743066 [TBL] [Abstract][Full Text] [Related]
19. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein. Chattopadhyay K; Bhatia S; Fiser A; Almo SC; Nathenson SG J Immunol; 2006 Sep; 177(6):3920-9. PubMed ID: 16951355 [TBL] [Abstract][Full Text] [Related]
20. Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice. Wang B; Liang S; Wang Y; Zhu XQ; Gong W; Zhang HQ; Li Y; Xia CM PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003434. PubMed ID: 25590646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]